• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON GMBH BBL CHROMAGAR MRSA II*; SEE H.10

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON GMBH BBL CHROMAGAR MRSA II*; SEE H.10 Back to Search Results
Catalog Number 257434
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problems No Consequences Or Impact To Patient (2199); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/08/2021
Event Type  malfunction  
Manufacturer Narrative
Common device name: culture media, antimicrobial susceptibility test, excluding mueller hinton agar.Medical device expiration date: unknown.(b)(6).A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.Device manufacture date: unknown.(b)(4).
 
Event Description
It was reported that while using bbl" chromagar" mrsa ii* (b)(6) results were obtained on patient samples.Repeat testing done with different media and the results were accurate.There was no report of patient impact.
 
Manufacturer Narrative
H.6.Investigation: it was reported that colonies of staph aureus appear to be white instead of pink.Complaint history review: the complaints trends were reviewed for a period covering 12 months.There were no confirmed complaints during that period on this product.Therefore, a trend could not be identified.Batch history record (bhr) review: the batch history review could not be performed as the batch number was not provided.Sample analysis: picture sample was not provided.As the batch number was not provided, a performance test with the retention samples could not be performed.However, as the shelf life of this product takes 10 weeks, the products which were produced within the last 10 weeks (02.November 2020 - 11.January 2021) were reviewed.As a release criteria, the performance of the products from that time frame were reviewed and no deviation could be detected.Evaluation results: at this stage of our investigation, we have excluded any systemic failure in our production process.No deviation could be found during the qc performance test.Investigation conclusion: based on the evaluation of the report and based on the qc test results, the complaint was not confirmed.A corrective and preventive action will not be implemented as a trend could not be identified.A definite root cause could not be determined.H3 other text : see h.10.
 
Event Description
It was reported that while using bbl¿ chromagar¿ mrsa ii* false negative results were obtained on patient samples.Repeat testing done with different media and the results were accurate.There was no report of patient impact.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Type of Device
SEE H.10
Manufacturer (Section D)
BECTON DICKINSON GMBH
8-12 tullastrasse
heidelberg 69126
GM  69126
MDR Report Key11267416
MDR Text Key258598063
Report Number9680577-2021-00004
Device Sequence Number1
Product Code JSO
Combination Product (y/n)N
PMA/PMN Number
K092767
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,other,user facility
Type of Report Initial,Followup
Report Date 06/21/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/02/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Catalogue Number257434
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Date Manufacturer Received06/21/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-